Cleared Traditional

K803081 - QUANTICHECK CONTROL PLASMA

K803081 is an FDA 510(k) clearance for QUANTICHECK CONTROL PLASMA, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code GGQ cleared through the Traditional 510(k) pathway after a 102-day FDA review.

K803081 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1981
Decision
102d
Days
Class 2
Risk

K803081 is an FDA 510(k) clearance for the QUANTICHECK CONTROL PLASMA. Classified as Test, Prothrombin Consumption (product code GGQ), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on March 17, 1981 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 864.7720 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K803081

510(k) Number K803081 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 1980
Decision Date March 17, 1981
Days to Decision 102 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 88d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGQ Device Classification - Class 2, Special Controls

Product Code GGQ Test, Prothrombin Consumption
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7720
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.